Dexcom Sinks 30%+ After Hours Following Fiscal Q2 Revenue Miss
$DexCom (DXCM.US)$ tumbled more than 30% after hours Thursday after missing analyst estimates for its fiscal Q2 revenues, although the medical-device maker beat forecasts for quarterly earnings.
DXCM fell 33.2% to trade at $72.01 shortly before 4:30 p.m. ET after reporting quarterly revenues of $1 billion, slightly trailing to $10.4 billion consensus that analysts had reportedly expected.
However, the company's earnings came in at $0.43 per share, beating the $0.39 that analysts had reportedly forecast.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Director of Financial Content
Former top editor at Seeking Alpha, Fidelity.com, TheStreet.com and UPI.
416Followers
417Following
2084Visitors
Follow